Science Resources RSS Feeds
|
 |
 |
 |
Drug-eluting Stents Current Events | Drug-eluting Stents News | 7
|
| Page
7 of
31 |
601 Results |
|
|
|
Sort By:
Page Views | Date |
Abrupt withdrawal of drugs to prepare for surgery can be dangerous
(Editorial: The risks of interrupting drug treatment before surgery) Abruptly stopping drug treatments before surgery can be dangerous and increase the risk of postoperative complications, suggests an editorial in this week?s BMJ. Surgery, particularly major abdominal surgery, affects the rate at which stomach contents are emptied, so reducing... view more... (2000-09-19)
Developing better methods of 'blinding' doctors and patients in clinical trials
When trials are carried out to assess the effectiveness of a drug, it is an important to have a control group of patients who are not given the drug. view more (2006-10-31)
Adding steroid drug to MS treatment may reduce disease activity
Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone. view more (2009-04-30)
Disease activity increases after MS patients stop drug
People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity. view more (2007-09-13)
Illegal drug use could account for 1 million visits a year to emergency care in England
Illegal drug use could account for up to 1 million visits a year to emergency care departments and 400,000 admissions to hospital in England, suggests research in Emergency Medicine Journal. view more (2005-11-17)
XDR TB in South Africa traced to lack of drug susceptibility testing
In South Africa, the 2001 implementation of the World Health Organization's anti-tuberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis (XDR TB). view more (2007-10-23)
New approach to treating heart attacks reduces risk of life-threatening complications
Transferring heart attack patients to specialized hospitals to undergo angioplasty within six hours after receiving clot-busting drugs reduces the risk of life-threatening complications including repeat heart attacks, according to a new study from St. Michael's Hospital and Southlake Regional Hospital. view more (2009-06-25)
Doubts raised about illegal drug use surveys
A scientific study reported in two related articles in the Journal of Drug Issues raises serious doubts about the nation's illegal drug use surveillance programs. view more (2006-03-03)
One in four hospital prescribing errors “potentially serious”
Around one in four hospital drug errors is “potentially serious,” and likely to harm patients, suggests a pilot study from one major teaching hospital, reported in Quality and Safety in Health Care. view more (2002-12-03)
European drug regulations need to change, say experts
European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts in this week's BMJ. view more (2007-10-19)
New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008
Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). view more (2008-10-13)
Engineers, doctors at UCLA develop novel material that could help fight arterial disease
A fortuitous discovery that grew out of a collaboration between UCLA engineers and physicians could potentially offer hope to the nearly 10 million Americans who suffer from peripheral arterial disease. view more (2009-11-30)
Prison drug services in Kent, Surrey and Sussex failed by lack of aftercare available to prisoners after release
The greatest threat to the success of prison-based drug treatments is the lack of aftercare available to prisoners after their release, according to a review published by the Centre for Health Service Studies at the University of Kent. The review, which is part of a wider programme of work evaluating the outcome effectiveness of drug treatment... view more... (2003-07-11)
High prescribing family doctors much more likely to see drug company reps frequently
Family doctors with high annual drug bills for their practices are significantly more likely to see drug company reps almost every day or at least once a week, reveals a representative survey of General Practitioners in England. view more (2003-02-04)
Toward a less expensive version of the anti-flu drug Tamiflu
Scientists have developed an alternative method for producing the active ingredient in Tamiflu®, the mainstay for fighting H1N1 and other forms of influenza. view more (2010-01-14)
'Erasing' drug-associated memories may stop drug addiction relapses
'Erasing' drug-associated memories may prevent recovering drug abusers from relapsing, researchers at the University of Cambridge have discovered. view more (2008-08-13)
Study: Before a CT scan or angiogram, many people should take inexpensive drug to protect kidneys
As more and more Americans undergo CT scans and other medical imaging scans involving intense X-rays, a new study suggests that many of them should take a pre-scan drug that could protect their kidneys from damage. view more (2008-02-19)
Potential cancer drug may offer new hope for asthma patients
A drug being tested to treat cancer could also help patients suffering from asthma, research has suggested. view more (2009-12-10)
Why are the best malaria drugs not being used in Africa?
Despite changes in policy in many African countries, most cases of malaria are still treated with old drugs that often fail, say researchers in this week's BMJ. view more (2005-09-30)
'LOTRONEX AND THE FDA: A FATAL EROSION OF INTEGRITY' (p 1544)
Controversy surrounding the licensing of Lotronex (a drug for irritable bowel syndrome (IBS)) and the US Food and Drug Administration (FDA) is uncovered in a Commentary article in this week's issue of THE LANCET. In March last year THE LANCET published a randomised trial detailing the efficacy and safety of alosetron (Lotronex) for women with IBS.... view more... (2001-05-16)
|
|
| Page
7 of
31 |
601 Results |
|
|
|
Sort By:
Page Views | Date |
|
|
